lithium carbonate has been researched along with Neurodegenerative Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coburn, KL; Doonan, SM; Lauterbach, EC; Mendez, MF; Shillcutt, SD; Victoroff, J | 1 |
| Fukunaga, K; Han, F; Morioka, M; Shioda, N | 1 |
2 review(s) available for lithium carbonate and Neurodegenerative Diseases
| Article | Year |
|---|---|
Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Brain; Clonazepam; Desipramine; Dibenzothiazepines; Dopamine Agonists; Humans; Lithium Carbonate; Maprotiline; Melatonin; Neurodegenerative Diseases; Neuroprotective Agents; Olanzapine; Parkinson Disease; Pramipexole; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Valproic Acid | 2010 |
[Novel therapeutic strategy for neurogenesis in the neurodegenerative disorders].
Topics: Animals; Cognition; Donepezil; Drug Design; Extracellular Signal-Regulated MAP Kinases; Hippocampus; Humans; Indans; Lithium Carbonate; Nerve Regeneration; Neurodegenerative Diseases; Piperidines; Stimulation, Chemical; Valproic Acid; Vanadium Compounds | 2008 |